Recent Potential Noninvasive Biomarkers in Necrotizing Enterocolitis

Necrotizing enterocolitis (NEC) is a rare but devastating gastrointestinal disease that predominately affects preterm neonates. Numerous studies have revealed that NEC is strongly associated with very low birth weight, degree of prematurity, formula feeding, infection, hypoxic/ischemic injury, and e...

Full description

Bibliographic Details
Main Authors: Kewei Wang, Guozhong Tao, Zhen Sun, Karl G. Sylvester
Format: Article
Language:English
Published: Hindawi Limited 2019-01-01
Series:Gastroenterology Research and Practice
Online Access:http://dx.doi.org/10.1155/2019/8413698
id doaj-aa01e11aacfc4cce8b14df309c483b0f
record_format Article
spelling doaj-aa01e11aacfc4cce8b14df309c483b0f2020-11-25T00:14:41ZengHindawi LimitedGastroenterology Research and Practice1687-61211687-630X2019-01-01201910.1155/2019/84136988413698Recent Potential Noninvasive Biomarkers in Necrotizing EnterocolitisKewei Wang0Guozhong Tao1Zhen Sun2Karl G. Sylvester3Department of Gastrointestinal Surgery, The First Hospital of China Medical University, Shenyang, 110001 Liaoning Province, ChinaDepartment of Surgery, Stanford University School of Medicine, Stanford, CA 94305, USADepartment of Surgery, Stanford University School of Medicine, Stanford, CA 94305, USADepartment of Surgery, Stanford University School of Medicine, Stanford, CA 94305, USANecrotizing enterocolitis (NEC) is a rare but devastating gastrointestinal disease that predominately affects preterm neonates. Numerous studies have revealed that NEC is strongly associated with very low birth weight, degree of prematurity, formula feeding, infection, hypoxic/ischemic injury, and enteric dysbiosis. Given these clinical associations, the search for a deeper understanding of disease pathogenesis has led to an intense interest in the discovery and development of noninvasive biomarkers of NEC from stool, urine, and serum. Biomarkers for NEC may serve at least two general purposes of urgent unmet need: to improve diagnostic accuracy and disease prediction and to reveal the mechanism of the disease. This review will provide an overview of recent research focused on clinical NEC and highlight the advances that were made within the past five years towards the development of noninvasive diagnostic biomarkers.http://dx.doi.org/10.1155/2019/8413698
collection DOAJ
language English
format Article
sources DOAJ
author Kewei Wang
Guozhong Tao
Zhen Sun
Karl G. Sylvester
spellingShingle Kewei Wang
Guozhong Tao
Zhen Sun
Karl G. Sylvester
Recent Potential Noninvasive Biomarkers in Necrotizing Enterocolitis
Gastroenterology Research and Practice
author_facet Kewei Wang
Guozhong Tao
Zhen Sun
Karl G. Sylvester
author_sort Kewei Wang
title Recent Potential Noninvasive Biomarkers in Necrotizing Enterocolitis
title_short Recent Potential Noninvasive Biomarkers in Necrotizing Enterocolitis
title_full Recent Potential Noninvasive Biomarkers in Necrotizing Enterocolitis
title_fullStr Recent Potential Noninvasive Biomarkers in Necrotizing Enterocolitis
title_full_unstemmed Recent Potential Noninvasive Biomarkers in Necrotizing Enterocolitis
title_sort recent potential noninvasive biomarkers in necrotizing enterocolitis
publisher Hindawi Limited
series Gastroenterology Research and Practice
issn 1687-6121
1687-630X
publishDate 2019-01-01
description Necrotizing enterocolitis (NEC) is a rare but devastating gastrointestinal disease that predominately affects preterm neonates. Numerous studies have revealed that NEC is strongly associated with very low birth weight, degree of prematurity, formula feeding, infection, hypoxic/ischemic injury, and enteric dysbiosis. Given these clinical associations, the search for a deeper understanding of disease pathogenesis has led to an intense interest in the discovery and development of noninvasive biomarkers of NEC from stool, urine, and serum. Biomarkers for NEC may serve at least two general purposes of urgent unmet need: to improve diagnostic accuracy and disease prediction and to reveal the mechanism of the disease. This review will provide an overview of recent research focused on clinical NEC and highlight the advances that were made within the past five years towards the development of noninvasive diagnostic biomarkers.
url http://dx.doi.org/10.1155/2019/8413698
work_keys_str_mv AT keweiwang recentpotentialnoninvasivebiomarkersinnecrotizingenterocolitis
AT guozhongtao recentpotentialnoninvasivebiomarkersinnecrotizingenterocolitis
AT zhensun recentpotentialnoninvasivebiomarkersinnecrotizingenterocolitis
AT karlgsylvester recentpotentialnoninvasivebiomarkersinnecrotizingenterocolitis
_version_ 1725389108621082624